SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/38BBB487CFA37192FDFA75918B3A4A3A7D6650274CCA7A76AE710D85FC0803E81051D9582E9EFA1600113490B80409F0>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/38BBB487CFA37192FDFA75918B3A4A3A7D6650274CCA7A76AE710D85FC0803E81051D9582E9EFA1600113490B80409F0
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/38BBB487CFA37192FDFA75918B3A4A3A7D6650274CCA7A76AE710D85FC0803E81051D9582E9EFA1600113490B80409F0
http://www.w3.org/2000/01/rdf-schema#comment
"patient's fibroblasts demonstrated markedly reduced QARS amino acylation activity in vitro"
xsd:string
http://purl.uniprot.org/uniprot/#_83CF49032FBB672F9F568236BC99BB2DB217D63D743E704DC275C8607EF4C1612705D613A445A5CB92D667CC596A27DE
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/38BBB487CFA37192FDFA75918B3A4A3A7D6650274CCA7A76AE710D85FC0803E81051D9582E9EFA1600113490B80409F0
http://purl.uniprot.org/uniprot/Q9BUZ3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/38BBB487CFA37192FDFA75918B3A4A3A7D6650274CCA7A76AE710D85FC0803E81051D9582E9EFA1600113490B80409F0
http://purl.uniprot.org/uniprot/#_Q9BUZ3-mappedCitation-28620870
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/38BBB487CFA37192FDFA75918B3A4A3A7D6650274CCA7A76AE710D85FC0803E81051D9582E9EFA1600113490B80409F0